Propiedad y actividad de insiders de Terns Pharmaceuticals, Inc. (TERN): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $52.95 |
| Capitalización | $4.8B |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-05-05 | Azelby Robert | D-Return | 90,000 | $372K |
| 2026-05-05 | Azelby Robert | D-Return | 1,697 | $59K |
| 2026-05-05 | Turner Heather D | D-Return | 45,000 | $184K |
| 2026-05-05 | Turner Heather D | D-Return | 64,000 | $365K |
| 2026-05-05 | Turner Heather D | D-Return | 1,697 | $59K |
| 2026-05-05 | Tripuraneni Radhika | D-Return | 64,000 | $136K |
| 2026-05-05 | Tripuraneni Radhika | D-Return | 45,000 | $184K |
| 2026-05-05 | Tripuraneni Radhika | D-Return | 10,657 | $48K |
| 2026-05-05 | Tripuraneni Radhika | D-Return | 4,676 | $32K |
| 2026-05-05 | Tripuraneni Radhika | D-Return | 32,000 | $224K |
Balance (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $82.5M | $12.3M | $74.9M | $47.7M | $143.2M | $79.9M | $161.4M | $524.7M |
| Inversiones a Corto | $4.4M | $7.3M | 0 | $118.3M | $139.9M | $183.5M | $196.7M | $494.2M |
| Cuentas por Cobrar | 0 | 0 | $12.7M | 0 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $88.5M | $22.2M | $90.9M | $166.9M | $285.2M | $267.4M | $362.1M | $1.02B |
| Inmovilizado Material | $261000 | $961000 | $1.2M | $1.0M | $1.8M | $1.0M | $1.5M | $884000 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $89.1M | $23.9M | $92.3M | $168.1M | $287.0M | $268.5M | $363.9M | $1.03B |
| Cuentas por Pagar | $914000 | $1.6M | $935000 | $2.1M | $1.6M | $2.5M | $2.1M | $1.7M |
| Deuda a Corto | 0 | 0 | $12.9M | 0 | 0 | 0 | $428000 | 0 |
| Pasivos Corrientes | $2.4M | $5.0M | $22.8M | $6.8M | $8.5M | $11.9M | $15.7M | $16.4M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $16.8M | $5.6M | $23.7M | $7.8M | $10.1M | $13.2M | $18.1M | $18.6M |
| Reservas | -$23.3M | -$91.9M | -$131.9M | -$182.1M | -$242.4M | -$332.6M | -$421.5M | -$517.7M |
| Patrimonio Neto | $72.2M | $4.2M | $68.6M | $160.3M | $276.9M | $255.4M | $345.9M | $1.01B |
| Deuda Total | 0 | 0 | $12.9M | 0 | $1.2M | $603000 | $1.3M | $919000 |
| Deuda Neta | -$86.9M | -$19.6M | -$62.0M | -$166.0M | -$281.9M | -$262.8M | -$356.8M | -$1.02B |
| Capital Circulante | $86.1M | $17.3M | $68.0M | $160.1M | $276.7M | $255.5M | $346.5M | $1.01B |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 62.41 |
| Piotroski F-Score | 3 |
| Altman Z-Score | 121.84 |
Rentabilidad
| Rentabilidad sobre capital | -20.02% |
| Rentabilidad sobre capital invertido | -10.91% |
| Rentabilidad sobre activos | -9.39% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Empresas relacionadas: AMLX · ELVN · IMTX · INBX · NKTR · ORIC · PGEN
Explorar sector: Healthcare · Biotechnology
Más secciones de TERN: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones